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Abstract
Migratory lung dendritic cells (DCs) transport viral antigen from the lungs to the draining mediastinal lymph nodes (MLNs)
during influenza virus infection to initiate the adaptive immune response. Two major migratory DC subsets, CD103
+ DCs
and CD11b
high DCs participate in this function and it is not clear if these antigen presenting cell (APC) populations become
directly infected and if so whether their activity is influenced by the infection. In these experiments we show that both
subpopulations can become infected and migrate to the draining MLN but a difference in their response to type I interferon
(I-IFN) signaling dictates the capacity of the virus to replicate. CD103
+ DCs allow the virus to replicate to significantly higher
levels than do the CD11b
high DCs, and they release infectious virus in the MLNs and when cultured ex-vivo. Virus replication
in CD11b
high DCs is inhibited by I-IFNs, since ablation of the I-IFN receptor (IFNAR) signaling permits virus to replicate
vigorously and productively in this subset. Interestingly, CD103
+ DCs are less sensitive to I-IFNs upregulating interferon-
induced genes to a lesser extent than CD11b
high DCs. The attenuated IFNAR signaling by CD103
+ DCs correlates with their
described superior antigen presentation capacity for naı ¨ve CD8
+ T cells when compared to CD11b
high DCs. Indeed ablation
of IFNAR signaling equalizes the competency of the antigen presenting function for the two subpopulations. Thus, antigen
presentation by lung DCs is proportional to virus replication and this is tightly constrained by I-IFN. The ‘‘interferon-
resistant’’ CD103
+ DCs may have evolved to ensure the presentation of viral antigens to T cells in I-IFN rich environments.
Conversely, this trait may be exploitable by viral pathogens as a mechanism for systemic dissemination.
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Introduction
Influenza virus replicates productively in the epithelial cells of
the respiratory tract [1,2]. In close contact to the infected epithelial
cells lies a network of specialized antigen presenting cells (APCs)
known as dendritic cells (DCs) [3,4]. Two major subsets of lung DCs
known as CD103
+ DCs and CD11b
high DCs can be identified in the
steady-state [5,6,7,8]. Following influenza virus infection these cells
migrate to the draining mediastinal lymph nodes (MLNs) loaded with
viral antigens (Ag) [9,10,11,12] to initiate T cell responses that are
critical for virus clearance and recovery from infection [13,14,15].
The strategic localization of lung DCs adjacent to the productively
infected epithelial cells ensures a supply of viral antigen for presen-
tation to T cells, but also makes DCs an ideal target for virus infection.
Following aerosol infection of mice [9,16], lung DCs begin to
migrate 2 days post-infection (dpi) concomitant with the abrupt
production of type I interferons (I-IFNs) and a myriad of other pro-
inflammatory cytokines [10,17]. I-IFNs have potent antiviral
activity limiting virus replication in infected cells by inducing the
transcription of hundreds of interferon-stimulated genes (ISGs)
[18,19,20,21]. The induction of ISGs or the antiviral state by I-
IFNs, and other related cytokines such as interferon-lambda, also
protect adjacent cells from infection thus restricting unabated
spread of the virus in the respiratory tract [22,23]. I-IFNs have also
been shown to function as natural adjuvants for maturing human
[24] and mouse DCs in vitro [25] and splenic DCs [26] in vivo. The
timing of I-IFN production and lung DC migration are temporally
related and it is not known to what extent I-IFNs influence the
function of these cells and their interaction with influenza virus.
Here we investigated the role of I-IFN in lung DC function
during influenza virus infection by studying the two major
migratory lung DC subsets: CD103
+ DCs and CD11b
high DCs.
We demonstrate a striking dichotomy in the sensitivity to I-IFN by
lung DCs that defines the level of virus replication and Ag
presentation to virus-specific naı ¨ve CD8
+ T cells. Additionally, our
findings show evidence that CD103
+ DCs permit productive
influenza replication and release infectious virus in the draining
lymph nodes while CD11b
high DCs do not.
Results
Influenza viral mRNA transcripts and infectious virus can
be demonstrated in the draining MLNs only after 2 days
post-infection
Our previous work showed that influenza virus suppressed
innate immunity in the lungs of mice for the first 2 days after
PLoS Pathogens | www.plospathogens.org 1 November 2011 | Volume 7 | Issue 11 | e1002345infection; a period we termed ‘‘the stealth phase’’ [10,27]. During
this privileged time, virus replication proceeds without instigating
inflammation or triggering the migration of lung DCs to the
MLNs. The end of the stealth phase is characterized by the abrupt
and vigorous production of I-IFNs and cytokines and the initiation
of Ag-bearing DC migration to the MLNs [10,28]. The cells
arriving in the MLNs were identified by the presence of
intracellular viral proteins and no determination was made as to
whether they were actually infected or simply carrying viral
proteins from the site of infection. To distinguish these two
possibilities we isolated MLNs from PR8-infected mice at defined
time points after aerosol infection and measured viral mRNA
transcripts from all 8 segments of influenza virus. As shown in
Figure 1A transcripts of all 8 segments were identified in the MLN
of infected mice. The kinetics of the appearance of the viral
mRNA in the MLN correlated perfectly with our previous results
for Ag-bearing DC migration [10] as it was only detectable
starting at 48 hpi, increased steadily, peaked by 96 hpi, and
persisted for at least 6 dpi. Homogenates collected from the MLN
demonstrated the presence of infectious virus particles at time
points that correlated with the appearance of viral mRNA and Ag-
bearing DC migration (Figure 1B) [9,10,11]. Inspection of
CD11c
+ cells in the MLNs by immunohistochemistry confirmed
viral antigen positive cells only after 48 hpi (Figure 1C).
Viral transcripts are carried to the MLNs by migratory cells
Migration of lung DCs is controlled by the chemokine receptor
CCR7 [8,29,30], and can be blocked by the use of pertussis toxin
(PTX) [7]. Intranasal PTX administration to infected mice
completely abolished the appearance of viral mRNA in the MLNs
(Figure 2A), and significantly reduced the numbers of CCR7
+ DCs
in the MLNs (Figure 2B) but had no effect on virus replication in
the lungs (Figure 2C). These data show that virus reaches the
draining MLNs by cell-associated transport rather than by leakage
of free virus through efferent lymphatics.
Infectious virus is carried by lung migratory DCs
Both of the major lung DC subsets, CD103
+ DCs and
CD11b
high DCs, transport viral Ag to the MLNs [11,31], but
whether it is in the form of infectious virus has not been
determined. Figure 3A-C shows a sorting strategy that was used to
isolate migratory DCs and other cells from the MLNs of infected
animals. Total migratory DCs were isolated and co-cultured (gate
V, Figure 3B) with virus permissive MDCK cells in vitro using
decreasing numbers of cells. The DC-depleted lymph node cells
were similarly cultured with MDCK cells (Figure 3B, gate i-iii
pooled together). Infectious virus was isolated from MDCK cells
cultured with 1,000 fold less migratory DCs than was observed
when DC-depleted lymph node cells were used indicating that
DCs were the primary transporters of infectious virus to the MLNs
(Figure 3D). Plaque immunostaining of MDCKs infected with
supernatant from these co-cultures confirmed the presence of live
virus (Figure 3D’).
CD103
+ DCs carry infectious virus from the lungs to MLNs
during infection
When individual migratory lung DC subsets were stained for
viral NP and visualized by confocal microscopy both CD103
+ DCs
(gate VI, Figure 3B) and CD11b
high DCs (gate VII, Figure 3B)
were found to have abundant intracellular Ag (Figure 3E). NP co-
localized to the nucleus in CD103
+ DCs (Figure 3E). In contrast,
NP in CD11b
high DCs surrounded but did not co-localize with the
nucleus (Figure 3E). To test which DC subset transferred infectious
virus particles to MDCKs in vitro, CD103
+ DCs and CD11b
high
DCs isolated from MLNs at 72 or 96 hpi were injected separately
into embryonated-chicken eggs (Figure 3F). 40 h later the allantoic
fluid was collected and tested for the presence of replicating virus
by agglutination of chicken red blood cells (RBCs). Only CD103
+
DCs (gate VI, Figure 3B) injected into eggs led to the production
of virus particles (Figure 3F), and the presence of infectious virus
was confirmed by plaque immunostaining of MDCKs infected
with the allantoic fluid from these samples (Figure 3F’). Neither
CD11b
high DCs (gate VII, Figure 3B) nor any other major
leukocyte populations (gate B: B220
+ cells; gate G: Gr1
+ cells; gate
P2: pDCs, Figure 3C) caused infectious virus production in
embryonated eggs (Figure 3F). Moreover, depletion of Langerin
+
CD103
+ DCs in PR8-infected Langerin-DTR EGFP mice [32]
reduced virus mRNA significantly in the MLNs (Figure 4A), with
no apparent compromise of lung virus titers (Figure 4B). Total
depletion of CD11c
+ cells from infected mice virtually eliminated
viral mRNA from the MLN [33] (Figure 4C and 4D).
Multicycle replication of PR8 virus in vitro requires L-1-
tosylamido-2-phenylethyl chloromethyl ketone treated-trypsin
(TPCK-trypsin) to promote HA cleavage and spread to uninfected
cells [34]. We next tested whether virus infection of MDCKs via
contact with migratory DCs was dependent on TPCK-trypsin. As
shown in Figure S1A, MDCK cells were infected in the absence of
trypsin when co-cultured for 2 days with migratory DCs (see black
arrows), showing that the transfer of infectious virus to MDCKs
was independent of an exogenous added protease. As expected,
subsequent robust spread of PR8 virus in MDCK cells was
dependent on TPCK-trypsin (Figure S1A). We repeated the
experiment with the closely related influenza strain known as
WSN virus that is not dependent on TPCK-trypsin for multicycle
replication [35,36]. MDCKs co-cultured with MLN-DCs sorted
from WSN infected mice were infected independently of trypsin
(Figure S1A). Similar to the ability of CD103
+ DCs to transfer
infectious virus to embryonated eggs (Figure 3), virus could be
transferred to MDCK cells upon co-culture with particular DC
subsets isolated from PR8 and WSN infected mice. Specifically,
only CD103
+ DC but not CD11b
high DCs caused ex-vivo virus
infection of MDCKs, and trypsin was necessary for multicycle
replication depending on the type of virus utilized (Figure S1B).
Author Summary
Migratory lung dendritic cells (DCs) control the initiation of
the adaptive immune responses to influenza virus by
expanding virus-specific T cells in draining lymph nodes
(MLNs) that will subsequently clear the pathogen from the
respiratory tract. Here we demonstrate that both subsets
of lung DCs, CD103
+ DCs and CD11b
high DCs become
infected by influenza virus in vivo and migrate to the MLNs,
but only CD103
+ DCs support productive virus replication.
Enhanced virus replication in CD103
+ DCs compared to
CD11b
high DCs was responsible for their superior antigen
presentation efficacy for naı ¨ve CD8
+ T cells and originated
from a difference in sensitivity of the two DC populations
to type I interferon (I-IFN). These data show that in contrast
to most other immune cell types, DCs can become
productively infected with influenza virus and I-IFN
operates as a master regulator controlling which DC
subset will present antigen during a viral infection. A
deeper understanding of basic innate and adaptive
immune response mechanisms regulated by I-FN may
lead to the development of cutting edge therapies and
improve vaccine efficacy against influenza and other
viruses.
Interferon on Lung DC Responses to Virus Infection
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+ DCs have an attenuated IFNAR signaling
response that results in enhanced virus replication
As shown here and in previous work, at 2 dpi a rapid
inflammatory response develops in the infected lung creating a
milieu of proinflammatory cytokines including I-IFNs. IFNAR
signaling in hematopoietic cells such as DCs induces the
expression of several ISGs that promote the antiviral state
[37,38,39]. The migration of lung DCs is initiated amidst this
inflammatory environment and it was surprising that viral
replication in the CD103
+ DCs was not inhibited by the antiviral
response triggered by I-IFN signaling [10,40].
Therefore we compared elements associated with IFNAR
signaling in steady state CD103
+ DCs and CD11b
high DCs sorted
from lungs of naı ¨ve mice (sorting strategy, Figure 5A). As shown in
Figure 5B, lung CD103
+ DCs show a reduced expression of Ifnar1
and Ifnar2 chains, the Jak1 kinase, as well as the transcription
factor Stat1, when compared to lung CD11b
high DCs. These four
genes represent key elements of the IFNAR receptor-signaling
complex. To determine if the decreased expression of IFNAR
signaling components translates into differences in ISG upregula-
tion CD103
+ DCs and CD11b
high DCs were sorted from the
MLNs during infection. Both DC subsets found in the MLNs of
infected animals showed upregulated ISGs, however wild type
CD11b
high DCs produced higher levels of the ISG gene products
than CD103
+ DCs, a difference that was abrogated in the absence
of IFNAR signaling (Figure 5C). In agreement with a differential
IFNAR signaling and ISG response by lung DCs, CD103
+ DCs
collected from MLNs of infected animals showed greater
Figure 1. Ag-bearing DC migration is associated with localized viral mRNA and virus replication in the MLNs. A. Total MLN cDNA
obtained from PR8-infected mice, at different time points after infection, was analyzed by qPCR for the 8 segments of influenza viral mRNA (NP
(nucleoprotein), HA (hemagglutinin), M (matrix protein), NS1 (non-structural protein 1), NA (neuraminidase), PB1 (polymerase PB1), PB2 (polymerase
PB2), and PA (polymerase PA) B. MLNs were isolated from PR8-infected mice and titers of infectious virus were determined. C. Cryostat sections of
MLNs isolated from PR8-infected mice were fixed, permeabilized and stained for CD11c (green), NP, M (red) and B220 (blue), and visualized with an
immunofluorescence microscope at 20x and 100x magnification. White arrows indicate Ag-bearing CD11c
+ cells at 20x magnification that were then
zoomed and photographed at 100x.
doi:10.1371/journal.ppat.1002345.g001
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high
DCs, expressing approximately ten times more viral NP mRNA
(Figure 5D). IFNAR deficiency exacerbated the virus burden in
CD103
+ DCs and increased significantly the viral mRNA content
in CD11b
high DCs (Figure 5D). The difference in virus
susceptibility between the CD103
+ DCs and CD11b
high DCs
can be observed at the earliest time points in DCs isolated directly
from the lungs of infected mice and mirrors the observations in
cells collected from the MLN (Figure 5E). These results suggest
that IFNAR signaling effectively restricts virus replication in
CD11b
high DCs whereas CD103
+ DCs are somewhat refractory to
this cytokine. Consistent with these findings, viral mRNA levels in
the MLN of infected IFNAR
-/- mice were significantly higher
than in wild type animals (Figure 1A) indicating that the amount of
virus transported to the MLN was higher in IFNAR
-/- mice
(Figure 5F).
IFNAR signaling determines infection and the division of
labor among lung DCs during influenza virus infection
To determine if the increase in viral mRNA seen in the MLNs
from IFNAR
-/- mice could result from enhanced virus replication
from migratory lung DCs, we sorted CD103
+ DCs and CD11b
high
DCs from infected IFNAR
-/- and IFNAR
+/+ mice at 3 and 4 dpi.
Individual DC subsets were injected into embryonated eggs and
the presence of infectious virus determined 40 h later by
hemagglutination of the allantoic fluid. In contrast to what was
observed with CD11b
high DCs from wild type animals, IFNAR
-/-
CD11b
high DCs were now permissive for productive infection by
influenza virus (Figure 6A).
Data from a number of laboratories have confirmed that
CD103
+ DCs are superior APCs for the priming of naı ¨ve CD8
+ T
cells [11,12,31]. Our data indicated a possible relationship
between virus replication and potent Ag presentation capacity.
Therefore we isolated CD103




-/- mice infected with PR8-OT-I virus to
determine whether suppressed viral replication in CD11b
high DCs
by IFNAR signaling would be the etiological reason behind this
difference in Ag presentation.
As anticipated, in vitro proliferation of naı ¨ve CD8
+ OT-I T cells





high DCs (Figure 6B). Strikingly,
OT-I T cell proliferation was comparable when both DC subsets
were isolated from IFNAR
-/- mice (Figure 6B) and the production
of interferon-gamma (IFN-c) from the OT-I T cells was almost
equivalent (Figure 6C). As a control, lymph-node resident CD8a
+
DCs, known to be potent APCs for CTL priming [12], were sorted
from PR8-OT-I infected IFNAR
+/+ and IFNAR
-/- mice (sorting
strategy, Figure S2) and co-cultured with OT-I cells in vitro
(Figure 6D). IFNAR
+/+ CD8a
+ DCs induced OT-I T cell
proliferation in vitro but not as robustly as IFNAR
+/+ CD103
+
DC. In contrast, IFNAR
-/- CD8a
+ DCs gained an enhanced
ability to present Ag in the absence of IFNAR signaling similarly to
what is observed for CD11b
high DCs. These data show that viral
replication in a given migratory DC population correlates with
priming efficiency of naı ¨ve CD8
+ T cells and the observed
differences in priming are not necessarily an intrinsic feature of
each DC subset and can be modulated by I-IFN signaling.
Discussion
The lung serves as a portal for the entry of a myriad of
respiratory viruses throughout the lifetime of the host. Induction of
cellular T cell immunity requires the obligate interaction of lung
DCs with viruses, with the imminent risk of infection. Our data
demonstrates that both lung DC subsets are infected with
influenza virus in vivo and this event does not impair their
migration to the MLNs or their function as APCs. By carefully
examining each lung DC subset we found that CD103
+ DCs had
much greater levels of viral mRNA and produced infectious virus
particles, a finding that challenges the widely held belief that
influenza virus replicates only in the lung epithelium [1,2]. On the
other hand, CD11b
high DCs expressed viral mRNA to a much
Figure 2. Blockade of lung migratory cells abolishes viral mRNA production in the MLNs. A. Two hours after infection, mice were
challenged intranasally with a single dose of pertussis toxin (PTX) or PBS (Ctrl), and thereafter a daily single dose of PTX or PBS was given i.p to each
mouse. Total RNA of MLNs was isolated at different time points after infection and viral mRNA (NP segment) was quantitated by qPCR. B. Absolute
numbers of CCR7
+ DCs in the MLNs during A/PR8 infection of mice were measured. Blue bars represent PBS mock treated mice and red bars mice
treated with PTX. C. Lung virus titers of influenza infected mice either challenged with PTX (red bars) or mock challenged with PBS (blue bars). Error
bars represent mean +/2 SD, * p,0.05.
doi:10.1371/journal.ppat.1002345.g002
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that these cells were abortively infected. The dramatic differences
in virus susceptibility were striking and led us to investigate
whether I-IFNs were uniquely sensed by both DC subsets.
Based on our previous observations, DCs begin to migrate in vivo
only when lung inflammation is triggered ,2 dpi with influenza
virus [10] [27]. At this time, the antiviral cytokines, I-IFNs, are
readily abundant but their effects on lung DC function were not
previously addressed. Importantly, I-IFNs confer only partial
protection to leukocytes during respiratory virus infection in vivo
[40], and this is further supported by in vitro experiments where
DCs and other leukocytes sustain some degree of viral transcrip-
tion even after treatment with very high concentrations of I-IFNs
[41,42]. Therefore, migrating lung DCs are not necessarily
refractory to influenza virus infection, even if they are I-IFN-
primed before encountering the virus. In the present study we
found that both lung DCs displayed an ‘‘interferon signature’’
(upregulation of ISGs) but the magnitude of the responses was
Figure 3. Migratory CD103
+ DCs are the major cell type carrying infectious virus particles to the MLNs. A–C. Isolation of different MLN
cell populations from influenza infected mice by cell sorting. A. Live gate for total MLN leukocytes shown as CD45
+ DAPI
- cells (gate II). B. Sorting
strategy to obtain total migratory DCs (gate V), individual CD103
+ DCs (gate VI), or CD11b
high DCs (gate VII), and non-DC MLN cells by pooling gates i,
ii, and iii during collection. All these cell populations were selected from the total CD45
+ live cell gate I. C. Alternative sorting strategy starting with
gate II, to obtain B220
+ cells (gate B), Gr1
+ cells (gate G), and pDCs (gate P2). D. Total migratory DCs (gate V) comprised of CD103
+ DCs and CD11b
high
DCs, or MLN non-DC cells (gates I, ii, and iii pooled) sorted at 3 dpi, were layered over MDCK cells in a 1:2 serial dilution, starting with 14,000 and
500,000 cells respectively, and were co-cultured in the presence of TPCK-trypsin for 3 days. Supernatants were assayed for infectious virus particles by
hemagglutination of RBCs. D’. Supernatants from MLN-DC/MDCK co-cultures were assayed for infectious virus by plaque immunostaining on MDCK
cells. E. Immunofluorescence of intracellular viral NP of sorted CD103
+DCs and CD11b
high DCs from infected mice at 3 dpi. F. Individual cell
populations, isolated by sorting at day 3 and 4 post-infection, as described above, were injected into 10-day old embryonated eggs, and 2 days later,
allantoic fluid was assayed for infectious virus particles by hemagglutination of RBCs. Each cell type at each time point was assayed in triplicate. F’.
Allantoic fluid from eggs injected with CD103
+ DCs was assayed for infectious virus particles by a plaque immunostaining assay on MDCK cells.
doi:10.1371/journal.ppat.1002345.g003
Figure 4. Depletion of total DCs or Langerin
+ DCs compromises viral load in the MLNs during infection. A. Langerin-DTR-EGFP mice
were injected i.p with DT daily, starting one day before infection with PR8. MLNs were harvested and NP mRNA was quantitated by qPCR. B. Lung
virus titers of DT-treated PR8 infected Langerin-DTR-EGFP mice (red bars) or mock treated (blue bars). C and D. CD11c-DTR-EGFP mice were used
instead, performing the same experiments as described in A and B. Error bars represent mean +/- SD, * p,0.05.
doi:10.1371/journal.ppat.1002345.g004
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CD103
+ DCs were found to be ‘‘inherently resistant’’ to IFNAR
signaling with an attenuated ISG response when compared to
CD11b
high DCs. Consequently, our confocal imaging data showed
nuclear localization of NP only in CD103
+ DCs but not in
CD11b
high DCs suggesting that the latter subset has a tight control
over virus replication mediated by stronger I-IFN signaling.
By ablating IFNAR signaling in CD11b
high DCs we could
increase their viral mRNA replication to levels comparable to wild
type CD103
+ DCs, and it was enough to promote infectious virus
production by CD11b
high DCs. Experimental evidence suggests a
divergent hematopoetic origin of lung DC subsets. CD103
+ DCs
appear to arise from pre-DC precursors while CD11b
high DCs are
monocyte derived [43,44,45,46], and this dichotomy could
determine unique IFNAR signaling differences. Currently we are
studying in more detail the underlying mechanisms explaining
why CD103
+ DCs have an attenuated IFNAR signaling and an
inherent susceptibility to virus infection. Some of these include,
inhibitory genes downstream of the IFNAR signaling pathway
[47,48], silencing of ISGs by epigenetic modifications of chromatin






- cells (gates I-IV). From gate IV individual DC subsets were further gated into CD103
+ DC (gate V) and
CD11b
high DC (gate VI) for separation by cell sorting. B. qPCR analysis of Ifnar genes and signaling related genes in lung CD103
+DCs (blue bars) and
lung CD11b
high DCs isolated from IFNAR
+/+ naı ¨ve mice. C. qPCR analysis of ISG expression by MLN CD103
+ DCs (blue bars) or MLN CD11b
high DCs
(green bars) sorted from either IFNAR
-/- or IFNAR
+/+ PR8-infected mice at 4 dpi. D. Expression of viral NP mRNA was determined by qPCR for
individual sorted MLN DC subsets as in (C). E. CD103
+ DCs and CD11b
high DCs isolated from the lungs of IFNAR
-/- or IFNAR
+/+ mice during the course
of PR8 infection were assayed for viral NP mRNA by qPCR. F. Total MLN cDNA obtained from PR8-infected IFNAR
-/- mice, at different time points after
infection, was analyzed for mRNA of the 8 segments of influenza virus (NP, HA, M, NS1, NA, PB1, PB2, PA) by qPCR. Error bars represent mean +/2 SD,
*p ,0.05.
doi:10.1371/journal.ppat.1002345.g005
Figure 6. IFNAR signaling determines class-I restricted antigen presentation by CD11b
high DCs during influenza virus infection. A.
Individual MLN DC subsets from IFNAR
+/+ or IFNAR
-/- mice were isolated by cell sorting at 3 and 4 dpi (described in Figure 3), and injected into 10-
day embryonated eggs. 2 days later, allantoic fluid was assayed for infectious virus particles by hemagglutination of RBCs. B. Sorted MLN CD103
+ DCs
and CD11b
high DCs from either IFNAR
+/+ or IFNAR
-/- mice infected with PR8-OT-I were isolated at 4 dpi and co-cultured for 60 h with CFSE-labeled
naı ¨ve OT-I CD8
+ T cells. T cell proliferation was analyzed by flow cytometry. C. IFN-c production of proliferating OT-I cultures (B) were assayed by
ELISA. D. Lymph-node resident CD8a
+ DCs isolated at 4 dpi from PR8-OT-I-infected IFNAR
+/+ or IFNAR
-/- mice were co-cultured with naı ¨ve OT-I CD8
+
T cells and proliferation was assessed by CFSE dilution. Error bars represent mean +/- SD, * p,0.05.
doi:10.1371/journal.ppat.1002345.g006
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or targeting of particular IFNAR signaling components [50], and
signaling by suppressor cytokines such as IL-10 [51].
The differential susceptibilities to virus infection by both lung
DCs suggested that the relative viral Ag abundance might act as a
limiting factor for peptide presentation by mayor histocompatibil-
ity class-I (MHC-I) molecules. CD103
+ DCs have been charac-
terized as APCs with superior abilities to prime naı ¨ve CD8
+ T cells
relative to CD11b
high DCs, though both are equally competent at
priming naı ¨ve CD4
+ T cells [11,31,52]. The underlying reason for
this fundamental difference has been ascribed to a division of labor
theory [53](first described for splenic DCs) where unique gene
programs define specialized machinery for MHC-II or MHC-I Ag
presentation within each DC subset [8]. Here we propose an
alternative model for this dichotomy based on the strength of their
response to I-IFNs that determines the efficiency in MHC-I Ag
presentation by controlling the level of virus replication within
each DC subset. The prominent natural susceptibility of CD103
+
DCs to virus infection may represent a mechanism that ensures
adequate MHC-I Ag presentation in a cytokine milieu dominated
by I-IFNs [10,40,42] leading to a higher density of peptide-MHC-
I complexes on the cell surface facilitated by constant degradation
of newly synthesized viral proteins [54,55,56,57]. On the other
hand, decreased virus replication in CD11b
high DCs reduces
peptide-MHC-I complex production, but loss of IFNAR signaling
boosts viral replication and their ability to prime naı ¨ve CD8
+ T
cells to levels comparable to CD103
+ DCs.
In this study, we did not address whether cross-priming [58]
represents a major component regulating Ag presentation by
CD103
+ DCs and CD11b
high DCs and further studies will be
required to address their relationship to direct infection of lung
DCs. Intriguingly, lymph node resident-CD8a
+ DCs known to be
potent APCs for cytotoxic T cells [12] were also boosted by the
absence of IFNAR signaling. CD8a
+ DCs might benefit from
increased numbers of virus-infected DCs (CD103
+ DC and
CD11b
high DC) in infected IFNAR
-/- mice that may undergo
cell death or release viral Ag that upon endocytosis may be used as
substrates for crosspriming. Alternatively, I-IFN signaling might be
responsible for lymph-node CD8a
+ DC crosspresentation in
influenza-infected wild-type mice ensuring optimal DC maturation
[26] and increased processing of viral antigen from migratory DCs
[12]; despite tight control of virus replication by I-IFN.
The hypersensitive IFNAR signaling by CD11b
high DCs may
divert these cells from naı ¨ve CTL priming to accomplish other
specific tasks in the immune response to influenza virus, which is
essentially multifactorial [15,59]. Some of these functions may
include, the production of high affinity IgG antibodies that may
depend upon the continuous migration of antigen-bearing
CD11b
high DCs derived from inflammatory monocytes [60,61,
62], restimulation of effector CD4
+ and CD8
+ T cells locally in the
lungs to trigger cytokine production and cytotoxicity [63], and as
potent cytokine and chemokine secretion machines activating and
recruiting innate and adaptive effector cell populations to the lungs
and lymph nodes [64]. Additionally, the robust I-IFN response
may have a protective role in sparing CD11b
high DCs from death
that may explain late antigen presentation during infection to
CTLs in the MLNs and lungs, which lingers long after the virus
has been cleared [65,66,67,68]. This knowledge about CD11b
high
DCs can potentially be harnessed to improve live DC vaccines in
human medicine. The likely human version of CD11b
high DCs is
easily derived from blood monocytes [69,70] and is commonly
used for in vivo immunization protocols [71]. IFNAR signaling
suppression in these cells may increase the replication of
recombinant attenuated viruses or vectors improving vaccine
efficacy for diverse diseases such as cancer [72,73,74] and HIV
[75,76,77,78].
A danger inherent to the unique sensitivity of CD103
+ DCs to
infection is that viruses likely evolved to exploit these cells as
shuttles and spread to multiple locations. Various viruses of
worldwide health concern, such as measles and varicella zoster use
the respiratory tract as an entry route from where they disseminate
systemically [79,80]. It would not be surprising, if these viruses
hijacked the CD103
+ DC equivalent in the human lung as an
initial Trojan horse, and upon arrival to the MLNs spread to other
susceptible cells that travel out of the lymph nodes into systemic
circulation. The same might be happening with particular
influenza virus strains in the human respiratory tract such as the
highly pathogenic H5N1 virus whose HA contains a polybasic
multi-cleavage site [81], and may target CD103
+ DCs to spread
hematogenously. Our experiments with WSN strain partially
demonstrate this phenomenon, since virus could spread from
CD103
+ DCs ex-vivo and infect MDCKs without the aid of an
exogenously added protease such as trypsin. It remains to be
determined whether in vivo, CD103
+ DCs can promote systemic
spread of viruses and whether lymph-node specific proteases aid
the cleavage of diverse hemagglutinins of influenza viruses.
Altogether, our findings are presented as a model summarized in
Figure 7, where the unique sensitivities to IFNAR signaling by
individual lung DC subsets have divergent consequences for the
adaptive immune response and as well as for viral pathogenesis.
Materials and Methods
Ethics statement
All animal work was conducted in agreement with approved
protocols by the Institutional Animal Care and Use Committee
(IACUC) at the Mount Sinai School of Medicine (Protocol
Numbers #: 96-308 and 08-0951) and in accordance with
guidelines in the Guide for the Care and Use of Laboratory
Animals of the National Institutes of Health. The program is fully
accredited by the Association for Assessment & Accreditation of
Laboratory Animal Care, International (AAALAC).
Mice and viruses
C57BL/6 wild type mice were purchased from Taconic or
Jackson laboratories. OT-I transgenic mice [82] were purchased
from Jackson Laboratories. OT-I mice were crossed to B6.SJL
mice to generate CD45.1
+ OT-I mice. C57BL/6 IFNAR
-/- mice
[83,84] were kindly provided by Dr. Wilson (Immunology
Department, University of Washington, USA). C57BL/6 Langerin
diphtheria toxin receptor (DTR) EGFP [32] mice were kindly
provided by Dr. Bernard Malissen (INSERM, Lyon, France).
C57BL/6 CD11c-DTR EGFP mice [33] were purchased from
Jackson laboratories. All mouse colonies were kept under
pathogen-free conditions at the Animal Facility of the Mount
Sinai School of Medicine.
Influenza virus strains A/PR/8/1934 (H1N1) (PR8), recombi-
nant PR8-OTI, and A/WSN/1933 (H1N1) (WSN) were grown in
10-day embryonated eggs (Charles Rivers, Spafas). PR8-OT-I
virus [85] was kindly provided by Dr. Peter Doherty and Dr. Paul
Thomas (St. Jude’s Research Children’s Hospital, Memphis, TN).
Mouse infection
Mice were infected using an Inhalation Exposure System A42X
(Glass-Col, USA). Influenza virus was diluted in PBS to obtain a
solution of 10
7.9 virus particles/12 ml. The virus solution was
placed inside of a sterile glass nebulizer connected to the infection
chamber. Total exposure time with aerosolized virus was 30 min.
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CD103
+ DCs are naturally resistant to IFNAR signaling and allow virus replication to higher levels leading to enhanced antigen presentation, when
compared to CD11b
high DCs that respond strongly to I-IFNs and impede virus replication and Ag presentation. B. The in vivo implications of virus
infection and unique IFNAR signaling by CD103
+ DCs and CD11b
high DCs during influenza virus infection and other respiratory viruses. Both lung DCs
begin to migrate to the MLNs when lung inflammation is initiated around 2 days post-infection, an event that is preceded by unabated virus
replication without an apparent innate response (stealth phase). IFNAR signaling is not protective in CD103
+ DCs and their inherent susceptibility to
virus infection may make them function as ‘‘Trojan horses’’ that transfer virus to other leukocytes in the MLNs and upon exit through efferent
lymphatics disseminate virus systemically.
doi:10.1371/journal.ppat.1002345.g007
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showed reproducible lung titers in several experiments at every
time point analyzed as described previously [9,10].
WSN infection of mice was performed by intranasal infection.
Briefly, mice were anesthetized with Avertin (Tribromoethanol,
Acros Organics) by intraperitoneal injection, and 1,000 plaque
forming units (pfu) of WSN virus in 35 ml PBS was applied
intranasally to each mouse. Mice were monitored until they were
fully awake and placed back into their cages.
Lymph node and lung cell preparations for flow
cytometry and fluorescence activated cell sorting (FACs)
MLNs from infected animals were mechanically dissociated and
digested in DMEM/1% FCS supplemented with 0.25 mg/ml
collagenase (Liberase type III, Roche) for 20 min at 37uC.
Collagenase was neutralized by adding sterile PBS containing
2% FCS and 2.5 mM EDTA for 5 min, and then passing the
dissociated cell suspension through a 70 mm strainer (BD
Biosciences). Single cell suspensions were treated with red-blood
cell lysis buffer (BD Biosciences) and resuspended in blocking
buffer (PBS containing 2% FCS and 10 mg/ml Fc-receptor block).
Lungs from infected mice were perfused with PBS to eliminate
excess blood. Lung lobes were gently dissociated using forceps and
digested for 50 min at 37uC in DMEM/1% FCS supplemented
with collagenase-D (Roche) at 0.25 mg/ml. Single cell suspensions
were obtained as described for MLNs.
For DC subset enumeration in the MLNs, lymph node cell
suspensions were stained with antibodies against multiple surface
antigens: anti-CD11c (clone HL-3), MHC-II (clone 2G9), Gr1
(Ly6C/Ly6G clone RBC865), Ly6C (Al-21), CD103 (clone 2E7),
CD11b (clone M1/70), B220 (clone RA3-6B2), CD8a (clone 53-
6.7). All antibodies were purchased from BD Bioscience,
eBiosciences, and Biolegend. Lymph node DCs were identified
as CD11c
high, MHC-II
high, B220 negative, and Gr1 negative cells.
Individual DC subsets were further gated as CD103
+ DC and
CD11b
high DC that were negative for CD8a. Lymph node
resident CD8a
+ DCs were identified in the MLN by gating on
CD11c
high MHC-II
intermediate cells as described elsewhere [86].
For enumeration of lung DC subsets, cell suspensions were stained
with antibodies against multiple surface antigens: anti-CD11c
(clone HL-3), MHC-II (clone 2G9), Gr1 (Ly6C/Ly6G clone
RBC865), Siglec-F (clone E50-2440), CD103 (clone 2E7), CD11b
(clone M1/70), B220 (clone RA3-6B2), CD8a (clone 53-6.7). Lung
DCs were identified as CD11c
high, MHC-II
high, Siglec-F negative,
B220 negative, and Gr1 negative cells. Individual lung DC subsets
were further gated as CD103
+ DCs and CD11b
high DCs. Samples
were acquired using a BD LSR-II flow cytometer at the Flow
Cytometry Core Facility, Mount Sinai School of Medicine. Dead
cells were excluded by DAPI staining. Data was analyzed using
FlowJo software (Treestar Corp.)
MLNs and lungs were isolated from infected and control mice
as described above under sterile conditions for cell sorting. Total
cell suspensions or enriched DC fractions were used to sort
individual CD103
+ DC, CD11b
high DC, and CD8a
+ DC subsets.
Other MLN cell types such as B cells, pDCs and Gr1
+ cells were
sorted from total cell suspensions. CD11c
+ cells were positively
selected using anti-CD11c beads (Miltenyi Biotech) or by negative
selection utilizing a cocktail of biotinylated mabs, that included
anti-Gr1 (clone RB6-8C5), anti-CD19 (clone 6D5), anti-Ter119
(clone Ter-119), anti-CD3 (clone 17A2), and anti-CD49b (clone
DX5) followed by incubation with anti-biotin beads (Miltenyi
Biotec). In both cases, cells were passed through LS magnetic
columns (Miltenyi Biotec) and positive or negative fractions were
collected depending on the method employed, then cells were
stained as described above and sorted using a BD Aria-II cell
sorter (Flow Cytometry Core Facility, Mount Sinai School of
Medicine).
Immunohistochemistry of mediastinal lymph nodes
MLNs isolated from PR8 infected mice, were embedded in
optimal cutting temperature (O.C.T) medium (Tissue-Tek), frozen
over dry ice, and stored at -80u C until further use. 8 mm sections
were cut with using a cryostat (Leica), placed over coated
microscope slides, and fixed with 4% paraformaldehyde in PBS
for 5 min at room temperature. Sections were blocked with PBS
containing 2% FCS and 1% mouse serum for 20 min. Then,
incubated with purified rat anti-B220 (clone RA3-6B2) and
purified hamster anti-CD11c (clone HL3) for 45 min, washed
twice with PBS and incubated with goat anti-rat Alexa-647
(Invitrogen) and goat-anti-hamster FITC (Jackson Immunore-
search) polyclonal sera, to visualize B220 (B cell areas) and CD11c
(DCs), respectively. Following surface staining, slides were
permeabilized with PBS containing Saponin 0.02% for 30 min
and then incubated with a mixture of biotinylated antibodies to
influenza NP (clone HT103) and M (2E10) proteins. Slides were
washed twice and then incubated with Streptavidin-Cy3 (Sigma).
Slides were air-dried, and mounted for fluorescence microscopy
using Prolong Antifade with DAPI (Invitrogen). Immunofluores-
cence was performed using a Zeiss Axioplan2 fluorescence
microscope. Images were analyzed using ImageJ software.
Determination of lung and lymph node virus titers
Plaque immunostaining assays were performed to quantitate
virus titers from infected mice. Lung homogenates from infected
mice (1 lung was homogenized in 1.8 ml of PBS containing 0.1%
Gelatin) were 10-fold serially diluted. 24 well plates were seeded
with Mardy-Darby Canine Kidney (MDCK) cells, 1 day before
the infection to achieve confluent monolayers. The plates were
washed 3 times with DMEM, and incubated for 1 hr with 100 ml
of infected-lung homogenates. After the inoculums were removed,
the cells were washed once with DMEM, and 500 ml of overlay
media (DMEM-F12 containing 0.6% agar (Oxoid), 0.5% Albumin
(MP biomedicals), 0.1% NaHCO3, antibiotics and 1 mg/ml
TPCK-trypsin (Worthington) ) was added on top. Infected
monolayers were incubated for 40 h at 37uC, and then fixed with
4% paraformaldehyde for 1 hr. Agar overlays were removed
gently under running water. Fixed monolayers were washed with
PBS twice, and incubated with chicken anti-PR8 polyclonal sera
(Charles River) followed by goat HRP-anti-chicken (Jackson
Immunoresearch). Plaques were visualized after incubation with
the True Blue substrate (KPL) that produces a blue precipitate by
an HRP mediated reaction. Plaque forming units (pfu) were
counted and virus titers were expressed as pfu/ml.
To determine virus titers in lymph nodes, MLNs were isolated
at different time points after infection and homogenized in 500 ml
of PBS. Immediately after homogenization, samples were pooled,
and 10-fold serial dilutions were injected in triplicates into 10-day
embryonated-chicken eggs. 40 h post-inoculation, allantoic fluid
was harvested to determine virus particles by hemagglutination of
red blood cells (RBCs). Endpoint titers were determined by the
method of Reed and Muench [87].
In vitro T cell proliferation assay
A CD8
+ T cell isolation kit (Miltenyi Biotec) was used to isolate
untouched OT-I CD8
+ T cells following manufacturer instruc-
tions. OT-I naive T cells were labeled with carboxyfluorescein
diacetate succinimidyl ester (CFSE) at a final concentration of
2.5 mM. Individual MLN CD11c
+ cell populations (CD103
+ DCs,
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high DCs and CD8a
+ DCs) were isolated at day 4 post-
infection from wild type or IFNAR
-/- mice infected with PR8-
OT-I and co-cultured in 96 well plates with CFSE-labeled OT-I
transgenic T cells at a ratio of 10,000 DCs to 50,000 CFSE-labeled
transgenic T cells per well. 60 h later, T cell proliferation was
quantitated by CFSE dilution using flow cytometry as described
elsewhere [9]. Dead cells were excluded using PI or DAPI staining.
Confocal microscopy of migratory DCs
A suspension of sorted CD103
+ DC and CD11b
high DCs in
100 ml, were placed over microscope poly-lysine coated slides
(Shandon) and let to adhere for 2 h at 37uC in an incubator inside
a humidified hybridization chamber (Sigma) in order to avoid
evaporation of the media. After the incubation time was over, the
media was rapidly aspirated (avoiding the cells to dry), and a drop
of ,100 ml of freshly prepared 4% paraformaldehyde in PBS was
added to fix the adherent cells at room temperature. After 3 min,
the solution was aspirated and replaced with fresh paraformalde-
hyde 4% (100 ml per sample) and the cells were fixed for additional
15 min. Cells were permeabilized using a solution of Saponin
0.02% dissolved in PBS. Slides were blocked with PBS containing
1% FBS, 1% mouse serum (Jackson Immunoresearch) and
Saponin 0.02% for 20 min, and stained for viral NP with
biotinilated-HT103 monoclonal antibody for 30 min at room
temperature. Followed by 3 washes in Saponin-PBS, secondary
staining was performed using Streptavidin-Cy3 (Sigma).
Slides were air-dried and Prolong Antifade with DAPI
(Invitrogen) was used as mounting media.
Fluorescence Microscopy was performed on a Zeiss Inverted
LSM 510 laser scanning confocal instrument mounted on a Zeiss
Axiovert 200M microscope. All images were acquired using a
100x oil objective. Images were analyzed with ImageJ software.
Determination of infectious virus particle production by
migratory DCs
MLN DCs from PR8 (day 2 to day 4 post-infection) or WSN
infected mice (day 3 post-infection) were sorted by FACs and co-
cultured for 3 days with confluent MDCK cells seeded on 96 well
plates in DMEM media containing 0.5% Albumin (MP biomed-
icals), 0.1% NaHCO3 and antibiotics. The culture media was
either supplemented or not with TPCK-trypsin (1 mg/ml).
Supernatants from these cultures were assayed for the presence
of replicating virus by hemagglutination of RBCs to determine
whether DCs were capable of transferring infectious virus particles
to MDCKs in vitro. Infected MDCK cells were visualized via
immunostaining with polyclonal anti-chicken PR8 developed with
horseradish peroxidase reaction with True Blue substrate as
described for plaque immunostaining assays. Images of infected
MDCK cells were acquired using a Nikon Eclipse TS100
microscope light microscopy. Alternatively, sorted DCs or other
sorted cells from the MLNs were injected directly into 10-day
embryonated eggs. 2 days later, allantoic fluid was isolated and
presence of virus was determined by hemagglutination of RBCs.
In parallel, allantoic fluid from these experiments was serially
diluted and used to infect MDCK cells to determine whether the
virus in these preparations was infectious as measured by plaque
immunostaining on MDCK cells.
Real-time quantitative PCR (qPCR)
Lungs or lymph nodes (3–5 pooled lymph nodes) from infected
mice were homogenized in 3 ml/sample of Trizol Reagent
(Invitrogen) and RNA was isolated as indicated by the manufac-
turer. Total mRNA was converted to cDNA by RT-PCR using
oligo-dT reaction (Affinity Script, Stratagene). cDNA was diluted
50 times in water and triplicate reactions were setup in 384-well
plates. qPCR reactions based on SYBR green detection, were
performed using a Lightcycler equipment (Roche, USA) all
reactions were normalized to a-tubulin as previously described
[88].
qPCR reactions with sorted DCs required mRNA amplifica-
tion. The WT-OVATION amplification Kit (Nugen, San Diego,
USA) was used for this purpose as described by the supplier.
The list of primers used in this study is the following:
M1/2 forward: 59-GGGAAGAACACCGATCTTGA-39; M1/
2 reverse: 59-CGGTGAGCGTGAACACAAAT-39; NA forward:
59-CATCTCTTTGTCCCATCCGT-39; NA reverse: 59-GTCC-
TGCATTCCAAGTGAGA-39; HA forward: 59-GAGGAGCT-
GAGGGAGCAAT-39; HA reverse: 59-GCCGTTACTCCGTT-
TGTGTT-39; PB1 forward: 59-CCTCCTTACAGCCATGGGA-
39; PB1 reverse: 59-GTGCTCCAGTTTCGGTGTTT-39; PB2
forward: 59-GGATCAGACCGAGTGATGGT-39; PB2 reverse:
59-CCATGCTTTAGCCTTTCGACT-39; PA forward: 59-CAT-
CAATGAGCAAGGCGAGT-39; PA forward: 59-GCCCCTGT-
AGTGTTGCAAAT-39; NP forward: 59-CAGCCTAATCAG-
ACCAAATG-39; NP reverse: 59-TACCTGCTTCTCAGTTCA-
AG-39;NS1 forward: 59-TTCACCATTGCCTTCTCTTC-39;
NS1 reverse: 59-CCCATTCTCATTACTGCTTC-39; Mx1
forward: 59-CAACTGGAATCCTCCTGGAA-39; Mx1 reverse:
59-GGCTCTCCTCAGAGGTATCA-39; Isg15 forward: 59-GA-
GCTAGAGCCTGCAGCAAT-39; Isg15 reverse: 59-CTTCTG-
GGCAATCTGCTTCT-39; Bst2 forward: 59- CAAACTCCTG-
CAACCTGACC-39;
Bst2 reverse: 59- CATTCTCAAGCTCCTTGATGC-39; Ifnar1
forward: 59 -GGTTGATCCGTTTATTCCATTC-39; Ifnar1
reverse: 59- CCACATGTTCCCGTCTTGT-39;
Ifnar2 forward: 59-CTTCGTGTTTGGTAGTGATGGT-39;
Ifnar2 reverse: 59-GGGGATGATTTCCAGCCGA -39; Stat1
forward: 59-CTTCAGCAGCTGGACTCCAA -39; Stat1 reverse:
59- GGTCGCAAACGAGACATCAT-39; Stat2 forward: 59-AA-
GAGGTGCAGCCCCCACCA-39; Stat2 reverse: 59-GCTGC-
GCCTGTTGGCTCTGA-39; Jak1 forward: 59- TGCAGGAGG-
GAGCCTGGCAT-39; Jak1 reverse: 59-AGCTTGCCCCAGGG-
GATCGT-39; Tyk2 forward: 59-AGCCATCTTGGAAGACAG-
CAA-39; Tyk2 reverse: 59-GACTTTGTGTGCGATGTGGAT-
39; a-tubulin forward: 59-TGCCTTTGTGCACTGGTATG-39;
a-tubulin reverse: 59-CTGGAGCAGTTTGACGACAC-39.
Lung DC migration blockade by pertussis toxin (PTX)
during infection
2 h after aerosol infection, mice were anesthetized and 2 mgo f
PTX dissolved in 35 ml of PBS was delivered intranasally to each
mouse. Once a day thereafter, mice received 0.5 mg of PTX i.p to
maintain the chemokine receptor blockade. MLNs and lungs of
mock and PTX treated mice were collected at day 1, 2, and 3 post-
infection. To further confirm ablation of lung DC migration,
absolute numbers of CCR7
+ CD11c
+ cells were determined in
infected mice treated with PBS or PTX. Mouse anti-CCR7
antibody (clone 4B12) was used for this experiment.
Diphtheria toxin depletion of DCs during infection
Langerin
+ CD103
+ DCs were depleted in PR8-infected
Langerin-DTR EGFP mice with an intraperitoneal (i.p) injection
of 1 mg of diphtheria toxin (DT, Sigma), 1 day before infection. At
day 0, mice were infected with aerosolized PR8 virus. Thereafter,
a daily dose of 200 ng was administered i.p to each mouse to
maintain the DC depletion. Lungs and MLNs were harvested
every day for RNA extraction and virus titer determination. For
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+ cell depletion, CD11c-DTR EGFP mice were
injected i.p with 4 ng/g (body weight) of DT, 1 day before PR8
infection. Thereafter daily doses of 30 ng of DT were administered
i.p up to day 3. Viral message in the MLNs was determined by
qPCR as described above. Lung titers were determined by plaque
immunostaining assay.
Cytokine ELISA
To determine the concentration of IFN-c from mixed DC-T
cell cultures, an ELISA kit from R&D (UK) was used according to
the manufacturer’s instructions.
Statistical analysis
Averaged results were expressed as means+/- standard
deviation. A two-tailed Student’s t test was used to determine
statistical significance of selected samples. P values, 0.05 (95%
Confidence) were considered to be significant. Graphs were
designed either in Excel or Graph Pad software.
Gene accession list
CD11c (name: Itgax, ID: 16411); CD11b (name: Itgam, ID:
16409); CD103 (name: Itgae, ID: 16407); Ifnar1 (name: Ifnar1, ID:
15975); Ifnar2 (name: Ifnar2, ID: 15976); Stat1 (name: Stat1, ID:
20846); Stat2(name: Stat2, ID: 288774); Jak1(name: Jak1, ID:
16451); Tyk2 (name: Tyk2, ID: 54721); Ly6C (name: Ly6c1, ID:
17067); Ly6G (name: Ly6g, ID: ); CD8a (name: Cd8a, ID: 12525);
Isg15 (name: Isg15, ID: 100038882); Mx1 (name: Mx1, ID: 17857);
Bst2 (name: Bst2, ID: 69550); IFN-c (name: Ifng, ID: 15978);
Siglec-F (name: Siglec5, ID: 233186); B220 (name: Ptprc, ID:
19264); CD45 (name: Ptprc, ID: 19264); Langerin (name: Cd207,
ID: 246278); CCR7 (name: Ccr7, ID: 12775); HA (name: HA, ID:
956529); NP (name: NP, ID: 956531); NS1 (name: NS1, ID:
956533); NA (name: NA, ID: 956530); PA (name: PA, ID:
956535); PB1 (name: PB1, ID: 956534); PB2 (name: PB2, ID:
956536); M ((name: M1, ID: 956527 and name: M2, ID: 956528 );
MHC-II (name: H2-Ab1, ID: 14961 and name: H2-Aa, ID:
14960).
Supporting Information
Figure S1 Migratory DCs can transfer infectious virus
to uninfected cells in the absence of TPCK-trypsin. A.
MLN-DCs (gate V, figure 3B) from PR8 or WSN infected mice
(day 3) were co-cultured with MDCK cells in the presence or
absence of TPCK-trypsin for 2 days. Virus replication was
assessed by HRP-based immunostaining of MDCK cells with a
chicken polyclonal antibody to influenza virus. Control wells were
stained with chicken normal serum followed by HRP-based
immunostaining. B. Sorted CD103
+ DCs and CD11b
high DCs
from PR8 or WSN-infected mice were co-cultured with MDCK
cells in the presence or absence of TPCK-trypsin and the culture
supernatants were assayed for infectious virus particles at day 2 by
hemmaglutination of RBCs.
(PDF)
Figure S2 Sorting strategy to isolate LN-resident CD8a
+
DCs during influenza virus infection. LN-resident CD8a
+
DCs were sorted by gating progressively through gates I-V to
eliminate contaminant lymph-node cells. From gate V, CD11c
high
MHC-II
intermediate DCs were further separated for cells that
express high levels of CD8a (gate VII), denoted in the manuscript
as LN-resident CD8a
+ DCs. From gate VI, CD11c
high MHC-
II
high cells were separated as previously shown in Figure 3, for
CD103
+ DCs (gate VIII) and CD11b
high DCs (gate IX).
(PDF)
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